CORE
🇺🇦
make metadata, not war
Services
Research
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
A phase 1b dose-escalation study of BYL719 plus binimetinib (MEK162) in patients with selected advanced solid tumors.
Author
Analia Azaro
Audrey Kaag
+10 more
Dejan Juric
Florence Hourcade-Potelleret
Francois Philippe Ringeisen
Heiko Maacke
Jayesh Desai
Jean-Charles Soria
Jordi Rodon Ahnert
Rajkumar Radhakrishnan
Sunil Sharma
Udai Banerji
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Dual targeting of RAF-MEK-ERK and PI3K-AKT-mTOR pathways in RAS-mutant cancers: Preclinical insights and institutional experience from a clinical trial of binimetinib (MEK162) plus BYL719.
Author
Adam Stewart
Alan David Smith
+12 more
Andrea Zivi
Audrey Kaag
David Lorente
Heiko Maacke
Johann Sebastian De Bono
Karim Rihawi
L Rhoda Molife
Nina Tunariu
Parames Thavasu
Rajkumar Radhakrishnan
Stanley B. Kaye
Udai Banerji
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
Separating Fact from Fiction in the Debate over Drone Proliferation
Author
Ansari Usman
Cronin Audrey Kurth
+22 more
Dobbing Mary
Geng Olivia
Heyns Christof
Hoffman Bruce
Jim Newton Leon Panetta
Kaag John
Kington Tom
Koebler Jason
LaGrone Sam
Macdonald Julia
Majumdar Dave
Marcus Jonathan
Matthew Fuhrmann
Micah Zenko Quoted
Michael C. Horowitz
Moyar Mark
Plaw Avery
Sarah E. Kreps
Villarejo Esteban
Wheeler Winslow
Wong Kelvin
Zegart Amy
Publication venue
'MIT Press - Journals'
Publication date
Field of study
No full text
Crossref
No full text
No full textNo full text